A putative role for the tobacco mosaic virus in smokers' resistance to COVID-19
Copyright © 2020 Elsevier Ltd. All rights reserved..
Reports from various countries suggest that tobacco smoking might protect from SARS-CoV-2 infection, since the prevalence of smoking in COVID-19 hospitalized patients is lower than in the respective general population. Apart from nicotine or other chemicals contained in tobacco smoke, we propose that a single-stranded RNA virus that infects tobacco leaves, tobacco mosaic virus (TMV), might be implicated in this effect. TMV, though non-pathogenic, is found in smokers' airways, and stimulates adaptive and innate immunity, with release of specific antibodies and interferons. The latter may have preventive and/or therapeutic effects against COVID-19. If confirmed by epidemiological and interventional studies, this might lead to the use of TMV as an immunological adjuvant against SARS-CoV-2 infection and COVID-19 disease.
Errataetall: |
CommentIn: Med Hypotheses. 2020 Nov;144:110251. - PMID 33254556 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:143 |
---|---|
Enthalten in: |
Medical hypotheses - 143(2020) vom: 25. Okt., Seite 110153 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
de Bernardis, E [VerfasserIn] |
---|
Links: |
---|
Themen: |
9008-11-1 |
---|
Anmerkungen: |
Date Completed 13.10.2020 Date Revised 28.03.2023 published: Print-Electronic CommentIn: Med Hypotheses. 2020 Nov;144:110251. - PMID 33254556 Citation Status MEDLINE |
---|
doi: |
10.1016/j.mehy.2020.110153 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM31338732X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM31338732X | ||
003 | DE-627 | ||
005 | 20231225150450.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.mehy.2020.110153 |2 doi | |
028 | 5 | 2 | |a pubmed24n1044.xml |
035 | |a (DE-627)NLM31338732X | ||
035 | |a (NLM)32763662 | ||
035 | |a (PII)S0306-9877(20)32233-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a de Bernardis, E |e verfasserin |4 aut | |
245 | 1 | 2 | |a A putative role for the tobacco mosaic virus in smokers' resistance to COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.10.2020 | ||
500 | |a Date Revised 28.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Med Hypotheses. 2020 Nov;144:110251. - PMID 33254556 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Ltd. All rights reserved. | ||
520 | |a Reports from various countries suggest that tobacco smoking might protect from SARS-CoV-2 infection, since the prevalence of smoking in COVID-19 hospitalized patients is lower than in the respective general population. Apart from nicotine or other chemicals contained in tobacco smoke, we propose that a single-stranded RNA virus that infects tobacco leaves, tobacco mosaic virus (TMV), might be implicated in this effect. TMV, though non-pathogenic, is found in smokers' airways, and stimulates adaptive and innate immunity, with release of specific antibodies and interferons. The latter may have preventive and/or therapeutic effects against COVID-19. If confirmed by epidemiological and interventional studies, this might lead to the use of TMV as an immunological adjuvant against SARS-CoV-2 infection and COVID-19 disease | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a Toll-Like Receptors |2 NLM | |
650 | 7 | |a Interferons |2 NLM | |
650 | 7 | |a 9008-11-1 |2 NLM | |
700 | 1 | |a Busà, L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medical hypotheses |d 1983 |g 143(2020) vom: 25. Okt., Seite 110153 |w (DE-627)NLM00007487X |x 1532-2777 |7 nnns |
773 | 1 | 8 | |g volume:143 |g year:2020 |g day:25 |g month:10 |g pages:110153 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mehy.2020.110153 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 143 |j 2020 |b 25 |c 10 |h 110153 |